These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 1056313)

  • 1. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
    de Vries JE; Meyering M; van Dongen A; Rümke P
    Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients.
    de Vries JE; Mendelsohn J; Bont WS
    Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
    Canevari S; Fossati G; Della Porta G
    J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
    de Vries JE; Rümke P
    Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

  • 6. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
    Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
    Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-51 release assay.
    Betton GR; Gorman NT
    J Natl Cancer Inst; 1978 Oct; 61(4):1085-93. PubMed ID: 279712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors.
    Berkelhammer J; Mastrangelo MJ; Laucius JF; Bodurtha AJ; Prehn RT
    Int J Cancer; 1975 Oct; 16(4):571-8. PubMed ID: 51835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
    Pross HF; Jondal M
    Clin Exp Immunol; 1975 Aug; 21(2):226-35. PubMed ID: 810282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.